These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15793849)

  • 21. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes after transfusion-associated hepatitis C.
    Tong MJ; el-Farra NS; Reikes AR; Co RL
    N Engl J Med; 1995 Jun; 332(22):1463-6. PubMed ID: 7739682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
    Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
    J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary HCV-antibodies; a follow-up cohort study of liver disease patients.
    Elsana S; Sikuler E; Yaari A; Shemer-Avni Y; Margalith M
    Clin Lab; 2001; 47(7-8):335-8. PubMed ID: 11499794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children.
    Rerksuppaphol S; Hardikar W; Dore GJ
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1357-62. PubMed ID: 15610308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C at the israeli national hemophilia center.
    Maor Y; Bashari D; Kenet G; Lalezari S; Lubetsky A; Luboshitz J; Schapiro JM; Avidan B; Bar-Meir S; Martinowitz U
    Haemophilia; 2006 Jan; 12(1):68-74. PubMed ID: 16409178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
    Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
    Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.
    Moreno M; Pérez-Alvarez R; Rodrigo L; Pérez-López R; Suárez-Leiva P
    J Viral Hepat; 2006 Jan; 13(1):28-33. PubMed ID: 16364079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus reinfection in injection drug users.
    Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
    Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
    Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
    Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
    Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C;
    J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
    Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
    J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.